Population based treatment strategy of H pylori in Qatar: Through clinical and demographic insights

Zohaib Ahmad Khan(Hamad Medical Corporation), Shiraz Salim Khan(Hamad Medical Corporation), Anil John(Pushpagiri Medical College), Alia Hani Mohammed Albattah(Hamad Medical Corporation), Khalid Al-Ejji(Hamad General Hospital), Hisham Ab Ib Swehli(Saint Francis Hospital), Mohamed A. Mahmoud(Lishman Health Foundation), Rajvir Singh(Hamad Medical Corporation), Saad Al Kaabi(Hamad General Hospital), Betsy Varughese(Hamad Medical Corporation)
Arab Journal of Gastroenterology
July 29, 2024
10.1016/j.ajg.2024.07.007
Cited by 3

Related Papers

Artificial intelligence in medical education - perception among medical students
|BMC Medical Education|2024|121
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study
|Lara D. Veeken|2012|106
Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study
|Journal of Gastroenterology and Hepatology|2005|73
The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole
|Annals of Tropical Medicine and Parasitology|2002|40
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations
|Annals of Tropical Medicine and Parasitology|2000|39